Loading...
Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
PURPOSE: In a recently completed 3-year, randomized, double-blind study, denosumab, a fully human monoclonal antibody against receptor activator of nuclear factor κB ligand, significantly increased bone mineral density and decreased new vertebral fractures in men receiving androgen deprivation thera...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2900763/ https://ncbi.nlm.nih.gov/pubmed/19836774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2009.08.048 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|